We studied constipation-related health care among children before and after constipation admission. Index admissions for constipation in 2010-2011 were identified in the Truven Marketscan Database, which includes children receiving Medicaid in 10 states. We measured number of and spending for outpatient constipation visits 12 months before and after index hospitalizations. We also measured spending for constipation hospitalizations and rehospitalization rate. (10%) were rehospitalized for constipation within 12 months. Constipation-related health care utilization increased after constipation admission. Median spending for one constipation admission was 50 times the median spending for 12 months of outpatient constipation visits.
Background
Constipation is a common pediatric condition, with a prevalence estimate as high as 30%.
1 Constipation is commonly managed in the outpatient setting 2, 3 and is the second most frequent ambulatory digestive diagnosis after reflux. 4 Clinical practice guidelines for constipation, including those from the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition, recommend disimpaction for acute constipation prior to initiation of maintenance therapy, though the route (oral vs nasogastric vs rectal) and setting (inpatient vs outpatient) for disimpaction are not specified. [5] [6] [7] We previously noted that inpatient utilization for pediatric constipation represented almost 15% of overall constipation spending among children receiving Medicaid. 8 However, the clinical effectiveness of inpatient versus outpatient constipation treatment for disimpaction has not been studied. These findings raise a number of important questions about children who are hospitalized for constipation. For example, do admissions for constipation usually occur after multiple preceding outpatient visits? Once children are admitted for constipation, does subsequent utilization for constipation decrease? How frequently are children readmitted for constipation treatment after a constipation-related hospitalization?
In this study, we describe the demographic and clinical characteristics of children insured by Medicaid who were hospitalized for constipation. Additionally, we describe constipation-related health care utilization for these children in the 12 months before and after hospitalization, including number of visits, spending, and prescription services. Because clinical superiority of inpatient versus outpatient disimpaction has not been established, we hypothesized that constipation-related health care utilization would not dramatically decrease following hospitalization for constipation.
Methods

Study Design and Setting
We conducted a retrospective cohort study utilizing the Truven MarketScan Medicaid claims database for the years 2009 to 2012. MarketScan contains enrollment information, retail prescription services, and inpatient and outpatient claims data for 6.9 million Medicaid enrollees ≤17 years old, from 10 to 12 deidentified states, depending on the year.
Study Population
We identified patients ≤17 years of age with a first inpatient visit for constipation in the years 2010 to 2011. The age of 17 years was chosen as the cutoff because Medicaid enrollment criteria typically change at age 18 years, and we wished to ensure an adequate period of enrollment to allow for all measured outcomes. For this analysis, patients had to be enrolled in Medicaid for at least 10 out of the 12 months surrounding the index admission (the 12-month period including the 6 months before and after admission) in order to ensure complete and similar data.
Inpatient constipation visits were defined as hospital visits with a primary International Classification of Diseases, 9th revision (ICD-9) code for constipation (564.0x), intestinal impaction (560.3x) or encopresis (307.7) or hospital visits with one of these as a secondary diagnosis code and another nonspecific abdominal diagnosis code as the primary code (see the appendix). The ICD-9 codes were similar to codes used by Choung et al 9 in a prior study of children with constipation. We recorded patient demographics and used ICD-9 codes to identify the presence of complex chronic conditions (CCCs) via Feudtner methodology, version 2. This is a validated methodology for identifying children with medical complexity, using ICD-9 codes to determine 12 different possible categories of chronic illness. 10 Constipation is not identified as a CCC using this methodology.
Outcomes
The main outcome measures were the number of constipation-related outpatient visits and spending for those visits (ie, reimbursement to providers from Medicaid), both measured in the 12 months before and 12 months after the index admission for constipation. The outpatient visits were identified using the same ICD-9 codes used to identify the inpatient visits. We also measured median and mean spending for the index admissions and identified rehospitalizations for constipation in the following 12 months. Finally, filled prescriptions for constipation treatment after outpatient constipation visits during the study period were identified in the retail pharmacy tables by searching within the therapeutic category "gastrointestinal agent" and therapeutic group "laxatives" (eg, docusate, senna, bisacodyl).
Analysis
The paired difference in constipation-related visits before and after constipation admission was compared using a Wilcoxon signed rank-sum test. The paired difference in constipation-related outpatient spending was also compared before and after admission with the same methodology. Demographic subgroups, including patients with CCCs, were also analyzed for the same outcomes. Additionally, demographics for patients having index admissions with no outpatient constipation visits in the preceding 12 months were compared with demographics for those having at least 1 preceding outpatient constipation visit using χ 2 tests. Calculations were performed using SAS 9.4 (SAS Institute, Cary, NC). P values <.05 were considered statistically significant.
Results
Study Population Demographic and Clinical Characteristics
We identified 780 children who met study enrollment criteria with a first admission for constipation in the years 2010-2011 (Table 1 ). The median age at admission was 8 years (IQR [4, 12] ). Children aged 6 to 12 years were the largest age group represented (45.6%). Approximately half (54%) of the children hospitalized for constipation had one or more CCCs.
Outpatient Constipation Visits Before and After Hospitalization
There were 1692 constipation-related outpatient visits in the 12 months before and 1938 in the 12 months after admission. A minority of the visits were seen in the emergency department: 161 (9.5%) before compared with 133 (6.9%) after admission (P = .004); 15.5% of the 780 hospitalized patients had an ED visit for constipation before and 12.6% had an ED visit after admission (P = .079).
The median number of constipation-related outpatient visits in the 12 months before admission was 1 (IQR [0, 3]), compared with 2 (IQR [0, 4]) after admission (P = .001); the mean number of visits was 2.17 before and 2.48 after admission (P = .01). A total of 319 patients (40.9%) had more outpatient visits after inpatient treatment than before, 243 (31.2%) had fewer visits, and 218 (27.9%) had the same number; 293 children (37.6%) had no outpatient visits for constipation in the 12 months before admission.
Within all strata of characteristics in Table 1 , no group had a lower number of constipation visits in the 12 months after the index admission. Children aged 1 to 2 and 3 to 5 years, male patients, black race, and children with 1 or more than 2 CCCs had a higher number of visits for constipation after admission.
Spending for Outpatient Constipation Visits
The median spending for outpatient constipation visits was $110 (IQR [0, 429]) in the 12 months before and $132 (IQR [0, 431]) in the 12 months after admission (P = .23). Mean outpatient spending was $516 before and $508 after admission (P = .90).
Laxative Prescriptions
A small minority (3.9%) of patients filled a prescription for a therapeutic laxative in the 12 months preceding the index hospitalization, compared with 4.6% after hospitalization (P = .5). No patient filled a prescription for more than 1 laxative.
Characteristics of Hospitalizations for Constipation, Including Readmissions
Of the 780 patients hospitalized for constipation, 694 (89.0%) had a study ICD-9 code as the primary diagnosis ( Table 2 ). The most frequently identified ICD-9 code was constipation (564.0x, 83%). Median length of stay for the hospitalizations was 2 days (IQR [1, 3] ). Median and mean spending for the index hospitalizations were $5295 (IQR [2756, 8267] ) and $7565, respectively. Also, 78 patients (10%) had one or more rehospitalizations for constipation within 12 months of the index admission; 14 patients (1.8%) had 2 or more rehospitalizations.
Comparison of Index Admissions With Versus Without Preceding Outpatient Constipation Visits
The demographics and number of CCCs were compared in hospitalized children with versus without outpatient constipation visits in the preceding 12 months (Table 3) . There were no differences between the 2 groups. Children admitted with no preceding outpatient constipation visit 
Discussion
The main findings from this study include that among children receiving Medicaid who were hospitalized for constipation, constipation-related utilization did not decrease after hospitalization compared with the year before hospitalization. Actually, 40% of children had no outpatient visit for constipation in the year preceding admission. In part related to that low level of utilization, outpatient visits and constipation treatment increased in the year following hospital admission. Despite this escalation in constipation management, readmissions for constipation were common. The hospitalizations for constipation were costly, with median spending for 1 hospitalization being almost 50 times the median spending for 12 months of outpatient constipation visits. Given the large relative expense of inpatient versus outpatient constipation treatment in children and the unknown clinical superiority of one setting versus the other, the practice of hospitalization for childhood constipation deserves further exploration. It is certainly possible that a number of these admissions were not initiated specifically for constipation treatment because we are only able to determine the discharge diagnosis codes. Thus, some patients may have been admitted for a nonspecific complaint, such as abdominal pain, and could have then been diagnosed with constipation during the admission. However, almost 90% of hospitalizations had a constipation-related ICD-9 code as the primary diagnosis. Additionally, we noted no difference in characteristics between those admitted with and without a prior outpatient constipation visit.
There are several possible interpretations for the increase in outpatient constipation visits after hospitalization for constipation. First, this may represent high disease burden among the hospitalized patients, requiring intensive treatment, initially inpatient and continuing into the outpatient setting. The high disease burden itself could be a result of underrecognition, undertreatment, and/or significant comorbidities. The large proportion of children hospitalized without prior outpatient constipation visit suggests undertreatment, though the high percentage of children with CCCs also suggests a role for comorbidities. Either of these processes suggests a potential role for better outpatient screening and/ or treatment, particularly among children with medical complexity. A second possible interpretation for the increase we noted in outpatient visits is closer outpatient constipation management by the primary physician after the sentinel event of a constipation admission. One other possibility to consider, however, is that inpatient disimpaction may not drastically change the clinical trajectory of the problem. The relatively high rate of readmission for constipation suggests that hospital admission for clean out may not be in itself sufficient treatment for acute constipation-at least not without good subsequent outpatient care. The readmission rate we identified for constipation treatment within 12 months (10%) compares similarly to studies of 12-month asthma readmissions, reported at 10.9% to 19.5%. 11, 12 Asthma is also similar to constipation in being a prevalent pediatric diagnosis. 13 One important difference between the 2 diseases is that asthma is commonly listed as an ambulatory care sensitive condition, in which high-quality outpatient care is believed to reduce the need for inpatient care, 14 whereas constipation is not. As noted in the introduction, trials comparing inpatient with outpatient constipation treatments are lacking. There is, however, ample evidence that outpatient disimpaction for acute constipation can be effective, including open-label trials of PEG 3350 15 and PEG + electrolytes, 16 a retrospective study favorably comparing PEG + electrolytes to enemas, 17 and 2 prospective studies of PEG 3350 versus enemas showing equal efficacy. 18, 19 Establishing the effectiveness of outpatient constipation treatment in decreasing subsequent need for inpatient care would be a key step in the establishment of constipation as ambulatory care sensitive.
Our study does have some important limitations. Our data are retrospective and may have missed some cases of constipation if other diagnosis codes than the ones we studied were utilized. Our study is drawn from patients receiving Medicaid, who may differ from patient populations with other pay sources. Prescription data are difficult to interpret in this data set because many laxatives, including PEG 3350, are available over the counter and may not generate a Medicaid claim; we may, therefore, significantly underestimate the number of children using medication for constipation. Finally, we are unable to measure variation in utilization at the state or institutional level, so our results represent an average, which may not reflect practice at some institutions.
There are important implications to consider from our study. The almost 40% of children admitted for constipation without prior outpatient constipation care suggests an outpatient management gap, though further investigation is necessary to determine how much improved recognition of and treatment for constipation could have avoided the need for the hospitalizations observed in the present study. The potential value in avoiding these hospitalizations, however, is reflected in the 50-fold higher median cost of 1 hospitalization compared with 12 months of outpatient constipation treatment. This topic would benefit from further study, particularly prospective trials aimed at identifying best treatment for acute disimpaction and standardized trials of constipation treatment targeted toward avoiding hospitalization.
